Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I trial of AK1960 in healthy adults and patients with chronic kidney disease
jRCT2031250621Phase 1Recruiting
- Sponsor
- Asahi Kasei Corporation
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of AK1960 in chronic kidney disease (CKD) (2 arms), sponsored by Asahi Kasei Corporation. Primary endpoints: Pharmacokinetic endpoints, Safety endpoints and 1 more. Started Feb 2026; status: recruiting.
02
Drugs
AK1960
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2031250621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250621.